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Alternative vector control 
methods to manage the 
Zika virus outbreak: 
more haste, less speed 
In their Comment in The Lancet 
Global Health (March, 2016),1 
Laith Yakob and Thomas Walker 
present the current epidemiological 
situation of the Zika virus outbreak 
in the Americas. They argue that, in 
the absence of a vaccine, the ongoing 
use of insecticides or the destruction 
of mosquito breeding sites provides 
little hope for the containment of 
this disease. Consequently, they 
highlight two novel techniques 
that in their view could provide 
imminent relief from Zika virus and 
other vectored diseases. The ﬁ rst one 
is the continuous mass release of 
genetically engineered mosquitoes 
that are partly sterile into the wild. The 
second approach relies on the use of 
a vertically inherited endosymbiotic 
bacterium to restrict arboviruses’ 
replication in mosquitoes. Although 
the theoretical potential of these 
novel biotechnological techniques is 
apparent to many, an imminent role 
in their use to contain the Zika virus 
is likely to prove premature. As of 
yet, no scientific reports have been 
published on the capacity of either 
technique to reduce diseases in human 
populations. Furthermore, the direct 
evidence that the Release of Insects 
carrying Dominant Lethal genes (RIDL) 
approach is eﬀ ective in reducing the 
size of the adult female Aedes aegypti 
population is currently based on 
one published study (appendix).2
With respect to the effect of 
endosymbiotic bacteria on viral 
replication or transmission, it is 
pertinent that although data exist for 
at least four viral species, the Zika virus 
is not one of them.3 The proposed link 
to the current Zika virus situation also 
makes the untested assumption that 
either technique could be very rapidly 
scaled up from the very small numbers 
of households used in their existing 
experimental work and still be proven 
as resource eﬃ  cient.
Despite the pressing need for 
solutions to the rapidly expanding 
Zika virus transmission, in our opinion 
it is hard to posit a substantial role for 
either approach until direct evidence 
shows a reduced human disease 
burden.4 While we acknowledge 
that to hold novel or experimental 
techniques to unrealistically high 
standards is counterproductive, it 
is surely uncontroversial to suggest 
that diverse and credible data must 
be publicly available before resources 
and attention are diverted away 
from current control programmes. 
Furthermore, in the speciﬁ c context of 
ongoing mosquito control it is essential 
that proponents of any new approaches 
(biotechnological or otherwise) make 
eﬀ orts not to undermine conﬁ dence 
in techniques likely to remain part of 
frontline responses. 
Increasing insecticide resistance is 
undoubtedly making control more 
difficult for some mosquito species, 
but the assertion that insecticides 
and the destruction of breeding 
sites cannot be part of highly 
successful control programmes is 
not supported by recent history. Use 
of insecticides and destruction of 
mosquito breeding sites had a central 
role in simultaneously eliminating 
Aedes aegypti from 18 continental 
countries, including Brazil, between 
1947 and 1962.5 Eﬀ ectively ﬁ ghting 
mosquitoes and the diseases they 
transmit has generally required 
community participation in the 
application of sustainable and cost-
effective approaches. Historical 
success and failures of vector control 
should be scrutinised to help avoid 
the allure of innovations that do not 
yet possess a suitably solid evidence 
base. New control techniques should 
be developed and used, but equally 
the value of available techniques 
should not be overlooked. When 
these available techniques are applied 
with strategic vision, they can yield 
impressive results.
See Online for appendix
